Literature DB >> 30969007

Metabolites study on 5-O-methylvisammioside in vivo and in vitro by ultra high performance liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.

Xueyan Fan1, Xiaochen Liu1, Caifeng Meng1, Ruina Liu1, Zijian Zhang2, Chunying Wang1.   

Abstract

5-O-Methylvisammioside is one of major chromones of Radix Saposhnikoviae possessing definite pharmacological activities, but there are few reports with respect to the metabolism of 5-O-methylvisammioside. In this work, metabolites in vivo were explored in male Sprague-Dawley rats and in vitro investigated on rat intestinal bacteria incubation model and were identified by using ultra high performance liquid chromatography/quadrupole time-of-flight mass spectrometry. An online data acquisition method based on a multiple mass defect filter and dynamic background subtraction was developed to trace all probable metabolites. As a result, 26 metabolites in vivo (including 18, 15, 10, and 10 in rat urine, faece, bile, and blood) and 7 metabolites in vitro were characterized, respectively. Additionally, the main metabolic pathways in vivo and in vitro, including deglycosylation, deglycosylation + demethylation, deglycosylation + oxidation, N-acetylation, and sulfate conjugation, were summarized by calculating the relative content of each metabolite. The obtained results significantly enriched our knowledge about 5-O-methylvisammioside metabolism and will lead to a better understanding of its safety and efficacy.
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  5-O-methylvisammioside; mass spectrometry; metabolites; traditional Chinese medicine; ultra high performance liquid chromatography

Year:  2019        PMID: 30969007     DOI: 10.1002/jssc.201900001

Source DB:  PubMed          Journal:  J Sep Sci        ISSN: 1615-9306            Impact factor:   3.645


  1 in total

1.  A novel strategy for the characterization of glaucocalyxin A metabolites in vivo and in vitro by UHPLC-Q-TOF-MS based on DDA and DIA data acquisitions.

Authors:  Wenjing Sun; Yiran Jin; Shuai Guan; Mengxin Yang; Miaoting Zhang; Jiali Hou; Yingfeng Du
Journal:  RSC Adv       Date:  2020-03-11       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.